Global Ketorolac Injection Market Research Report 2025(Status and Outlook)

March 2025 | 227 pages | ID: G02438B180FFEN
Bosson Research

Abstracts

Report Overview

Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.

This report provides a deep insight into the global Ketorolac Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Ketorolac Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Ketorolac Injection market in any manner.

Global Ketorolac Injection Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Market Segmentation (by Type)

15mg/ml

30mg/ml

Market Segmentation (by Application)

Hospital

Clinics

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Ketorolac Injection Market
• Overview of the regional outlook of the Ketorolac Injection Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Ketorolac Injection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Ketorolac Injection
1.2 Key Market Segments
  1.2.1 Ketorolac Injection Segment by Type
  1.2.2 Ketorolac Injection Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL KETOROLAC INJECTION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Ketorolac Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Ketorolac Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL KETOROLAC INJECTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Ketorolac Injection Product Life Cycle
3.3 Global Ketorolac Injection Sales by Manufacturers (2020-2025)
3.4 Global Ketorolac Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Ketorolac Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type
3.8 Ketorolac Injection Market Competitive Situation and Trends
  3.8.1 Ketorolac Injection Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Ketorolac Injection Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 KETOROLAC INJECTION INDUSTRY CHAIN ANALYSIS

4.1 Ketorolac Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF KETOROLAC INJECTION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Ketorolac Injection Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Ketorolac Injection Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL KETOROLAC INJECTION MARKET BY REGION

6.1 Global Ketorolac Injection Market Size by Region
  6.1.1 Global Ketorolac Injection Market Size by Region
  6.1.2 Global Ketorolac Injection Market Size Market Share by Region
6.2 Global Ketorolac Injection Sales by Region
  6.2.1 Global Ketorolac Injection Sales by Region
  6.2.2 Global Ketorolac Injection Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Ketorolac Injection Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Ketorolac Injection Market Size by Type
7.3 North America Ketorolac Injection Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Ketorolac Injection Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Ketorolac Injection Market Size by Type
8.3 Europe Ketorolac Injection Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Ketorolac Injection Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Ketorolac Injection Market Size by Type
9.3 Asia-Pacific Ketorolac Injection Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Ketorolac Injection Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Ketorolac Injection Market Size by Type
10.3 South America Ketorolac Injection Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Ketorolac Injection Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Ketorolac Injection Market Size by Type
11.3 Middle East and Africa Ketorolac Injection Market Size by Application

12 KETOROLAC INJECTION MARKET PRODUCTION BY REGION

12.1 Global Production of Ketorolac Injection by Region(2020-2025)
12.2 Global Ketorolac Injection Revenue Market Share by Region (2020-2025)
12.3 Global Ketorolac Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Ketorolac Injection Production
  12.4.1 North America Ketorolac Injection Production Growth Rate (2020-2025)
  12.4.2 North America Ketorolac Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Ketorolac Injection Production
  12.5.1 Europe Ketorolac Injection Production Growth Rate (2020-2025)
  12.5.2 Europe Ketorolac Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Ketorolac Injection Production (2020-2025)
  12.6.1 Japan Ketorolac Injection Production Growth Rate (2020-2025)
  12.6.2 Japan Ketorolac Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Ketorolac Injection Production (2020-2025)
  12.7.1 China Ketorolac Injection Production Growth Rate (2020-2025)
  12.7.2 China Ketorolac Injection Production, Revenue, Price and Gross Margin (2020-2025)

13 KETOROLAC INJECTION MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Ketorolac Injection Sales Market Share by Type (2020-2033)
13.3 Global Ketorolac Injection Market Size Market Share by Type (2020-2033)
13.4 Global Ketorolac Injection Price by Type (2020-2033)

14 KETOROLAC INJECTION MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Ketorolac Injection Market Sales by Application (2020-2033)
14.3 Global Ketorolac Injection Market Size (M USD) by Application (2020-2033)
14.4 Global Ketorolac Injection Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Pfizer
  15.1.1 Pfizer Basic Information
  15.1.2 Pfizer Ketorolac Injection Product Overview
  15.1.3 Pfizer Ketorolac Injection Product Market Performance
  15.1.4 Pfizer Business Overview
  15.1.5 Pfizer SWOT Analysis
  15.1.6 Pfizer Recent Developments
15.2 Fresenius Kabi
  15.2.1 Fresenius Kabi Basic Information
  15.2.2 Fresenius Kabi Ketorolac Injection Product Overview
  15.2.3 Fresenius Kabi Ketorolac Injection Product Market Performance
  15.2.4 Fresenius Kabi Business Overview
  15.2.5 Fresenius Kabi SWOT Analysis
  15.2.6 Fresenius Kabi Recent Developments
15.3 Fosun Pharma (Gland Pharma)
  15.3.1 Fosun Pharma (Gland Pharma) Basic Information
  15.3.2 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Overview
  15.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Market Performance
  15.3.4 Fosun Pharma (Gland Pharma) Business Overview
  15.3.5 Fosun Pharma (Gland Pharma) SWOT Analysis
  15.3.6 Fosun Pharma (Gland Pharma) Recent Developments
15.4 Sagent Pharmaceuticals
  15.4.1 Sagent Pharmaceuticals Basic Information
  15.4.2 Sagent Pharmaceuticals Ketorolac Injection Product Overview
  15.4.3 Sagent Pharmaceuticals Ketorolac Injection Product Market Performance
  15.4.4 Sagent Pharmaceuticals Business Overview
  15.4.5 Sagent Pharmaceuticals Recent Developments
15.5 Hikma
  15.5.1 Hikma Basic Information
  15.5.2 Hikma Ketorolac Injection Product Overview
  15.5.3 Hikma Ketorolac Injection Product Market Performance
  15.5.4 Hikma Business Overview
  15.5.5 Hikma Recent Developments
15.6 Lunan Pharma
  15.6.1 Lunan Pharma Basic Information
  15.6.2 Lunan Pharma Ketorolac Injection Product Overview
  15.6.3 Lunan Pharma Ketorolac Injection Product Market Performance
  15.6.4 Lunan Pharma Business Overview
  15.6.5 Lunan Pharma Recent Developments
15.7 Alvogen
  15.7.1 Alvogen Basic Information
  15.7.2 Alvogen Ketorolac Injection Product Overview
  15.7.3 Alvogen Ketorolac Injection Product Market Performance
  15.7.4 Alvogen Business Overview
  15.7.5 Alvogen Recent Developments
15.8 Chengdu Brilliant Pharmaceuticals
  15.8.1 Chengdu Brilliant Pharmaceuticals Basic Information
  15.8.2 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Overview
  15.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Market Performance
  15.8.4 Chengdu Brilliant Pharmaceuticals Business Overview
  15.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
15.9 Athenex
  15.9.1 Athenex Basic Information
  15.9.2 Athenex Ketorolac Injection Product Overview
  15.9.3 Athenex Ketorolac Injection Product Market Performance
  15.9.4 Athenex Business Overview
  15.9.5 Athenex Recent Developments
15.10 Sichuan Medcalo
  15.10.1 Sichuan Medcalo Basic Information
  15.10.2 Sichuan Medcalo Ketorolac Injection Product Overview
  15.10.3 Sichuan Medcalo Ketorolac Injection Product Market Performance
  15.10.4 Sichuan Medcalo Business Overview
  15.10.5 Sichuan Medcalo Recent Developments
15.11 Julphar Bangladesh Ltd.
  15.11.1 Julphar Bangladesh Ltd. Basic Information
  15.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Product Overview
  15.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Product Market Performance
  15.11.4 Julphar Bangladesh Ltd. Business Overview
  15.11.5 Julphar Bangladesh Ltd. Recent Developments
15.12 Yung Shin Pharm
  15.12.1 Yung Shin Pharm Basic Information
  15.12.2 Yung Shin Pharm Ketorolac Injection Product Overview
  15.12.3 Yung Shin Pharm Ketorolac Injection Product Market Performance
  15.12.4 Yung Shin Pharm Business Overview
  15.12.5 Yung Shin Pharm Recent Developments
15.13 Tianjin Chase Sun Pharmaceutical
  15.13.1 Tianjin Chase Sun Pharmaceutical Basic Information
  15.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Overview
  15.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Market Performance
  15.13.4 Tianjin Chase Sun Pharmaceutical Business Overview
  15.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
15.14 ZISKA Pharmaceuticals
  15.14.1 ZISKA Pharmaceuticals Basic Information
  15.14.2 ZISKA Pharmaceuticals Ketorolac Injection Product Overview
  15.14.3 ZISKA Pharmaceuticals Ketorolac Injection Product Market Performance
  15.14.4 ZISKA Pharmaceuticals Business Overview
  15.14.5 ZISKA Pharmaceuticals Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Ketorolac Injection Market Size by Type (M USD)
Table 4. Global Ketorolac Injection Market Size by Application (M USD)
Table 5. Ketorolac Injection Market Size Comparison by Region (M USD)
Table 6. Global Ketorolac Injection Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Ketorolac Injection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Ketorolac Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Ketorolac Injection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2024)
Table 11. Global Market Ketorolac Injection Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Ketorolac Injection Manufacturing Sites and Area Served
Table 13. Manufacturers Ketorolac Injection Product Type
Table 14. Global Ketorolac Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Ketorolac Injection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Ketorolac Injection Market Size Comparison by Region (M USD)
Table 26. Global Ketorolac Injection Market Size by Region (2020-2033) & (M USD)
Table 27. Global Ketorolac Injection Market Size Market Share by Region (2020-2033)
Table 28. Global Ketorolac Injection Sales by Region (2020-2033) & (K MT)
Table 29. Global Ketorolac Injection Sales Market Share by Region (2020-2033)
Table 30. North America Ketorolac Injection Market Size by Country (2020-2033) & (M USD)
Table 31. North America Ketorolac Injection Sales by Country (2020-2033) & (K MT)
Table 32. North America Ketorolac Injection Sales by Type (K MT)
Table 33. North America Ketorolac Injection Market Size by Type (M USD)
Table 34. North America Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 35. North America Ketorolac Injection Market Size (M USD) by Type (2020-2033)
Table 36. North America Ketorolac Injection Sales by Application (K MT)
Table 37. North America Ketorolac Injection Market Size by Application (M USD)
Table 38. North America Ketorolac Injection Sales (K MT) by Application (2020-2033)
Table 39. North America Ketorolac Injection Market Size (M USD) by Application (2020-2033)
Table 40. Europe Ketorolac Injection Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Ketorolac Injection Sales by Country (2020-2033) & (K MT)
Table 42. Europe Ketorolac Injection Sales by Type (K MT)
Table 43. Europe Ketorolac Injection Market Size by Type (M USD)
Table 44. Europe Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 45. Europe Ketorolac Injection Market Size (M USD) by Type (2020-2033)
Table 46. Europe Ketorolac Injection Sales by Application (K MT)
Table 47. Europe Ketorolac Injection Market Size by Application (M USD)
Table 48. Europe Ketorolac Injection Sales (K MT) by Application (2020-2033)
Table 49. Europe Ketorolac Injection Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Ketorolac Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Ketorolac Injection Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Ketorolac Injection Sales by Type (K MT)
Table 53. Asia-Pacific Ketorolac Injection Market Size by Type (M USD)
Table 54. Asia-Pacific Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Ketorolac Injection Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Ketorolac Injection Sales by Application (K MT)
Table 57. Asia-Pacific Ketorolac Injection Market Size by Application (M USD)
Table 58. Asia-Pacific Ketorolac Injection Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Ketorolac Injection Market Size (M USD) by Application (2020-2025)
Table 60. South America Ketorolac Injection Market Size by Country (2020-2033) & (M USD)
Table 61. South America Ketorolac Injection Sales by Country (2020-2033) & (K MT)
Table 62. South America Ketorolac Injection Sales by Type (K MT)
Table 63. South America Ketorolac Injection Market Size by Type (M USD)
Table 64. South America Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 65. South America Ketorolac Injection Market Size (M USD) by Type (2020-2033)
Table 66. South America Ketorolac Injection Sales by Application (K MT)
Table 67. South America Ketorolac Injection Market Size by Application (M USD)
Table 68. South America Ketorolac Injection Sales (K MT) by Application (2020-2033)
Table 69. South America Ketorolac Injection Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Ketorolac Injection Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Ketorolac Injection Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Ketorolac Injection Sales by Type (K MT)
Table 73. Middle East and Africa Ketorolac Injection Market Size by Type (M USD)
Table 74. Middle East and Africa Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Ketorolac Injection Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Ketorolac Injection Sales by Application (K MT)
Table 77. Middle East and Africa Ketorolac Injection Market Size by Application (M USD)
Table 78. Middle East and Africa Ketorolac Injection Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Ketorolac Injection Market Size (M USD) by Application (2020-2033)
Table 80. Global Ketorolac Injection Production (K MT) by Region(2020-2025)
Table 81. Global Ketorolac Injection Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Ketorolac Injection Revenue Market Share by Region (2020-2025)
Table 83. Global Ketorolac Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Ketorolac Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Ketorolac Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Ketorolac Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Ketorolac Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Ketorolac Injection Sales by Type (K MT)
Table 89. Global Ketorolac Injection Market Size by Type (M USD)
Table 90. Global Ketorolac Injection Sales (K MT) by Type (2020-2033)
Table 91. Global Ketorolac Injection Sales Market Share by Type (2020-2033)
Table 92. Global Ketorolac Injection Market Size (M USD) by Type (2020-2033)
Table 93. Global Ketorolac Injection Market Size Share by Type (2020-2033)
Table 94. Global Ketorolac Injection Sales (K MT) by Application
Table 95. Global Ketorolac Injection Market Size by Application(M USD)
Table 96. Global Ketorolac Injection Sales by Application (2020-2033) & (K MT)
Table 97. Global Ketorolac Injection Sales Market Share by Application (2020-2033)
Table 98. Global Ketorolac Injection Market Size by Application (2020-2033) & (M USD)
Table 99. Global Ketorolac Injection Market Share by Application (2020-2033)
Table 100. Global Ketorolac Injection Sales Growth Rate by Application (2020-2033)
Table 101. Pfizer Basic Information
Table 102. Pfizer Ketorolac Injection Product Overview
Table 103. Pfizer Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Pfizer Business Overview
Table 105. Pfizer SWOT Analysis
Table 106. Pfizer Recent Developments
Table 107. Fresenius Kabi Basic Information
Table 108. Fresenius Kabi Ketorolac Injection Product Overview
Table 109. Fresenius Kabi Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Fresenius Kabi Business Overview
Table 111. Fresenius Kabi SWOT Analysis
Table 112. Fresenius Kabi Recent Developments
Table 113. Fosun Pharma (Gland Pharma) Basic Information
Table 114. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Overview
Table 115. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Fosun Pharma (Gland Pharma) Business Overview
Table 117. Fosun Pharma (Gland Pharma) SWOT Analysis
Table 118. Fosun Pharma (Gland Pharma) Recent Developments
Table 119. Sagent Pharmaceuticals Basic Information
Table 120. Sagent Pharmaceuticals Ketorolac Injection Product Overview
Table 121. Sagent Pharmaceuticals Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Sagent Pharmaceuticals Business Overview
Table 123. Sagent Pharmaceuticals Recent Developments
Table 124. Hikma Basic Information
Table 125. Hikma Ketorolac Injection Product Overview
Table 126. Hikma Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Hikma Business Overview
Table 128. Hikma Recent Developments
Table 129. Lunan Pharma Basic Information
Table 130. Lunan Pharma Ketorolac Injection Product Overview
Table 131. Lunan Pharma Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Lunan Pharma Business Overview
Table 133. Lunan Pharma Recent Developments
Table 134. Alvogen Basic Information
Table 135. Alvogen Ketorolac Injection Product Overview
Table 136. Alvogen Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Alvogen Business Overview
Table 138. Alvogen Recent Developments
Table 139. Chengdu Brilliant Pharmaceuticals Basic Information
Table 140. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Overview
Table 141. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Chengdu Brilliant Pharmaceuticals Business Overview
Table 143. Chengdu Brilliant Pharmaceuticals Recent Developments
Table 144. Athenex Basic Information
Table 145. Athenex Ketorolac Injection Product Overview
Table 146. Athenex Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Athenex Business Overview
Table 148. Athenex Recent Developments
Table 149. Sichuan Medcalo Basic Information
Table 150. Sichuan Medcalo Ketorolac Injection Product Overview
Table 151. Sichuan Medcalo Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Sichuan Medcalo Business Overview
Table 153. Sichuan Medcalo Recent Developments
Table 154. Julphar Bangladesh Ltd. Basic Information
Table 155. Julphar Bangladesh Ltd. Ketorolac Injection Product Overview
Table 156. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Julphar Bangladesh Ltd. Business Overview
Table 158. Julphar Bangladesh Ltd. Recent Developments
Table 159. Yung Shin Pharm Basic Information
Table 160. Yung Shin Pharm Ketorolac Injection Product Overview
Table 161. Yung Shin Pharm Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Yung Shin Pharm Business Overview
Table 163. Yung Shin Pharm Recent Developments
Table 164. Tianjin Chase Sun Pharmaceutical Basic Information
Table 165. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Overview
Table 166. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Tianjin Chase Sun Pharmaceutical Business Overview
Table 168. Tianjin Chase Sun Pharmaceutical Recent Developments
Table 169. ZISKA Pharmaceuticals Basic Information
Table 170. ZISKA Pharmaceuticals Ketorolac Injection Product Overview
Table 171. ZISKA Pharmaceuticals Ketorolac Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. ZISKA Pharmaceuticals Business Overview
Table 173. ZISKA Pharmaceuticals Recent Developments
List of Figures
Figure 1. Product Picture of Ketorolac Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Ketorolac Injection Market Size (M USD), 2024-2033
Figure 5. Global Ketorolac Injection Market Size (M USD) (2020-2033)
Figure 6. Global Ketorolac Injection Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Ketorolac Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Ketorolac Injection Product Life Cycle
Figure 13. Ketorolac Injection Sales Share by Manufacturers in 2024
Figure 14. Global Ketorolac Injection Revenue Share by Manufacturers in 2024
Figure 15. Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Ketorolac Injection Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Ketorolac Injection Revenue in 2024
Figure 18. Industry Chain Map of Ketorolac Injection
Figure 19. Global Ketorolac Injection Market PEST Analysis
Figure 20. Global Ketorolac Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Ketorolac Injection Market Size by Region
Figure 27. Global Ketorolac Injection Market Size Market Share by Region (2020-2033)
Figure 28. Global Ketorolac Injection Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Ketorolac Injection Market Size (M USD) by Country
Figure 33. USA Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Ketorolac Injection Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Ketorolac Injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Ketorolac Injection Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Ketorolac Injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Ketorolac Injection Market Size (M USD)by Type
Figure 40. North America Ketorolac Injection Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Ketorolac Injection Market Size (M USD) by Country
Figure 45. Germany Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Ketorolac Injection Market Size (M USD) by Type
Figure 56. Europe Ketorolac Injection Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Ketorolac Injection Market Size (M USD) by Country
Figure 61. China Ketorolac Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Ketorolac Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Ketorolac Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Ketorolac Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Ketorolac Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Ketorolac Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Ketorolac Injection Market Size (M USD) by Type
Figure 72. Asia-Pacific Ketorolac Injection Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Ketorolac Injection Market Size (M USD) by Country
Figure 77. Brazil Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Ketorolac Injection Market Size (M USD) by Type
Figure 84. South America Ketorolac Injection Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Ketorolac Injection Market Size (M USD) by Country
Figure 89. Saudi Arabia Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Ketorolac Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Ketorolac Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Ketorolac Injection Market Size (M USD) by Type
Figure 100. Middle East and Africa Ketorolac Injection Market Size (M USD) by Application
Figure 101. Global Ketorolac Injection Production Market Share by Region (2020-2025)
Figure 102. North America Ketorolac Injection Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Ketorolac Injection Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Ketorolac Injection Production (K MT) Growth Rate (2020-2025)
Figure 105. China Ketorolac Injection Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Ketorolac Injection Market Size by Type (M USD)
Figure 108. Sales Market Share of Ketorolac Injection by Type (2020-2033)
Figure 109. Sales Market Share of Ketorolac Injection by Type in 2024
Figure 110. Market Size Share of Ketorolac Injection by Type (2020-2033)
Figure 111. Market Size Share of Ketorolac Injection by Type in 2024
Figure 112. Global Ketorolac Injection Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Ketorolac Injection Market Size by Application(M USD)
Figure 115. Global Ketorolac Injection Market Share by Application
Figure 116. Global Ketorolac Injection Sales Market Share by Application (2020-2033)
Figure 117. Global Ketorolac Injection Sales Market Share by Application in 2024
Figure 118. Global Ketorolac Injection Market Share by Application (2020-2033)
Figure 119. Global Ketorolac Injection Market Share by Application in 2024
Figure 120. Global Ketorolac Injection Sales Growth Rate by Application (2020-2033)